Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Neoplasm | 2 | 2024 | 1997 | 0.630 |
Why?
|
| CD8-Positive T-Lymphocytes | 8 | 2023 | 4648 | 0.600 |
Why?
|
| Interleukins | 2 | 2022 | 796 | 0.580 |
Why?
|
| Cancer Vaccines | 1 | 2024 | 1041 | 0.540 |
Why?
|
| B-Lymphocytes | 2 | 2023 | 4793 | 0.390 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4415 | 0.340 |
Why?
|
| Melanoma | 1 | 2024 | 5706 | 0.250 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 6395 | 0.230 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 13586 | 0.210 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2022 | 240 | 0.160 |
Why?
|
| Antigens | 1 | 2023 | 1442 | 0.140 |
Why?
|
| Lupus Nephritis | 1 | 2020 | 327 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2022 | 724 | 0.130 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2014 | 23 | 0.120 |
Why?
|
| Neoplasms | 1 | 2023 | 22371 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2023 | 2323 | 0.110 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 3948 | 0.100 |
Why?
|
| Immunotherapy | 2 | 2024 | 4755 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3474 | 0.080 |
Why?
|
| Skin | 1 | 2023 | 4503 | 0.080 |
Why?
|
| Biosensing Techniques | 1 | 2014 | 662 | 0.080 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 1469 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2016 | 1412 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 2171 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22379 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14488 | 0.070 |
Why?
|
| Mice | 6 | 2023 | 82029 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 17140 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 5176 | 0.060 |
Why?
|
| Lichen Planus | 1 | 2023 | 70 | 0.050 |
Why?
|
| Animals | 7 | 2023 | 169246 | 0.050 |
Why?
|
| Epidermis | 1 | 2023 | 539 | 0.040 |
Why?
|
| Stroke | 1 | 2022 | 9755 | 0.040 |
Why?
|
| Humans | 9 | 2024 | 768166 | 0.040 |
Why?
|
| Pyridones | 1 | 2022 | 819 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2020 | 905 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2020 | 1968 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2022 | 4030 | 0.030 |
Why?
|
| Pseudomonas | 1 | 2014 | 124 | 0.030 |
Why?
|
| Warfarin | 1 | 2022 | 1493 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 11101 | 0.030 |
Why?
|
| Antibodies | 1 | 2021 | 2421 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6124 | 0.030 |
Why?
|
| Synthetic Biology | 1 | 2014 | 187 | 0.030 |
Why?
|
| Biopsy | 1 | 2023 | 6793 | 0.020 |
Why?
|
| Aspirin | 1 | 2022 | 3135 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15662 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5505 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 2065 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 9538 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2022 | 4852 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5703 | 0.020 |
Why?
|
| Kidney | 1 | 2020 | 7064 | 0.010 |
Why?
|
| Risk | 1 | 2016 | 9613 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9669 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 9419 | 0.010 |
Why?
|
| Female | 2 | 2021 | 397192 | 0.010 |
Why?
|
| Male | 2 | 2021 | 364719 | 0.010 |
Why?
|
Concepts
(58)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_